Reviewing Coinbase Global (NASDAQ:COIN) & ALT5 Sigma (NASDAQ:AIFC)

ALT5 Sigma (NASDAQ:AIFC) and Coinbase Global (NASDAQ:COIN) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends.

Profitability

This table compares ALT5 Sigma and Coinbase Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ALT5 Sigma	-2,483.94%	-68.25%	-62.43%
Coinbase Global	12.20%	4.16%	2.07%

Earnings & Valuation

This table compares ALT5 Sigma and Coinbase Global”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ALT5 Sigma	$24.84 million	3.38	-$344.51 million	N/A	N/A
Coinbase Global	$7.18 billion	6.07	$1.26 billion	$2.66	62.21

Coinbase Global has higher revenue and earnings than ALT5 Sigma.

Analyst Recommendations

This is a summary of current recommendations and price targets for ALT5 Sigma and Coinbase Global, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ALT5 Sigma	1	0	0	0	1.00
Coinbase Global	3	12	18	0	2.45

Coinbase Global has a consensus target price of $250.65, indicating a potential upside of 51.47%. Given Coinbase Global’s stronger consensus rating and higher probable upside, analysts plainly believe Coinbase Global is more favorable than ALT5 Sigma.

Insider & Institutional Ownership

6.3% of ALT5 Sigma shares are owned by institutional investors. Comparatively, 68.8% of Coinbase Global shares are owned by institutional investors. 0.2% of ALT5 Sigma shares are owned by company insiders. Comparatively, 16.7% of Coinbase Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

ALT5 Sigma has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. Comparatively, Coinbase Global has a beta of 3.35, indicating that its share price is 235% more volatile than the S&P 500.

Summary

Coinbase Global beats ALT5 Sigma on 12 of the 12 factors compared between the two stocks.

About ALT5 Sigma

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

About Coinbase Global

Coinbase Global, Inc. provides financial infrastructure and technology for the crypto economy in the United States and internationally. The company offers the primary financial account in the crypto economy for consumers; and a marketplace with a pool of liquidity for transacting in crypto assets for institutions. It also provides technology and services that enable developers to build crypto products and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.